West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$299.81 USD
+0.01 (0.00%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $299.98 +0.17 (0.06%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$299.81 USD
+0.01 (0.00%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $299.98 +0.17 (0.06%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Zacks News
Here's Why You Should Invest in Patterson Companies (PDCO) Stock
by Zacks Equity Research
Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and dental business.
Veeva Systems' (VEEV) New Offering to Optimize Lab Operations
by Zacks Equity Research
Veeva Systems' (VEEV) Vault LIMS is expected to help manufacturers optimize lab management and significantly simplify their systems landscape via a unified suite of quality and lab applications.
Here's Why You Should Invest in West Pharmaceutical (WST) Now
by Zacks Equity Research
West Pharmaceutical (WST) continues to gain momentum on the back of strength in Proprietary Products business.
3 High-Potential MedTech Stocks With More Than 50% Growth YTD
by Riya Anand
Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.
Masimo's (MASI) EMMA Capnography on Neonates Favored by New Study
by Zacks Equity Research
Masimo's (MASI) EMMA is likely to aid in maintaining an optimal range of PaCO2 in preterm infants undergoing mechanical ventilation in the neonatal intensive care unit.
Why West Pharmaceutical (WST) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider West Pharmaceutical (WST).
The Zacks Analyst Blog Highlights: West Pharmaceutical Services, The Mosaic Co, AutoZone, O'Reilly Automotive and Ulta Beauty
by Zacks Equity Research
The Zacks Analyst Blog Highlights: West Pharmaceutical Services, The Mosaic Co, AutoZone, O'Reilly Automotive and Ulta Beauty
S&P 500 Records a Broad-Based Rally YTD: 5 Top-Ranked Picks
by Nalak Das
We have narrowed down our search to five large-cap S&P 500 stocks that have strong growth potential for the rest of 2021. These are AZO, MOS, ULTA, ORLY, and WST.
Here's Why You Should Retain Masimo (MASI) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.
Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day
Bet on These 3 MedTech Growth Stocks for 2021 & Beyond
by Riya Anand
Stocks like West Pharmaceutical Services (WST), IDEXX Laboratories (IDXX) and Align Technology (ALGN) make great picks for the long term.
Here's Why You Should Retain Inogen (INGN) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems
3 Dental Stocks Poised to Perform Well in Second-Half 2021
by Trina Mukherjee
Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.
Top Ranked Momentum Stocks to Buy for September 15th
by Zacks Equity Research
CACC, UFPT, WST, and CASH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 15, 2021.
Here's Why You Should Invest in Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
by Zacks Equity Research
PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.
Here is Why Growth Investors Should Buy West Pharmaceutical (WST) Now
by Zacks Equity Research
West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.
HealthEquity (HQY) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) witnesses solid growth in HSAs and records robust Interchange revenues in the second quarter of fiscal 2022.
The Zacks Analyst Blog Highlights: Regeneron, Vertex Pharmaceuticals and West Pharmaceutical Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Regeneron, Vertex Pharmaceuticals and West Pharmaceutical Services
A Short Trading Week: Global Week Ahead
by John Blank
The trading week is shorted to four days for stocks listed solely in the U.S. In turn, this Global Week Ahead looks to be dominated by non-U.S. events.
What Makes West Pharmaceutical Services (WST) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
West Pharmaceutical (WST) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.